ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

ICL Fincorp plans to raise Rs 100 crore through a public issue of NCDs for business growth. The NCD will open on April 25, ...

Evogene's stock surged on news of ICL's acquisition of Lavie Bio's operations, strengthening ICL's position in ag-biologicals ...

ICL Israel Chemicals Ltd (ICL) is an Israel-based company that develops, manufactures, markets, and sells fertilizer and specialty chemicals. The company operates in three segments: Fertilizers ...

ICL Fincorp Ltd has announced the launch of its fifth public issue of secured, redeemable Non-Convertible Debentures (NCDs), ...

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product discovery and development, today announced the signing of a ...

ICL Group shows strong upside with bullish charts, solid cash flow, and improving fundamentals. Find out why ICL is a buy.

Lavie has previously teamed up with Bayer, Corteva and Syngenta to develop biopesticides and biostimulants via its ...

Evogene (EVGN) signed a definitive agreement under which ICL will acquire the majority of activity of Evogene’s subsidiary, Lavie Bio. As part ...

This transaction follows strategic investment by ICL Planet and more than two years of close collaboration between ICL and Lavie Bio, focused on developing innovative bio-stimulant solutions for ...